Fortress Biotech (FBIO) Return on Invested Capital (2017 - 2025)
Fortress Biotech (FBIO) has 6 years of Return on Invested Capital data on record, last reported at 15.38% in Q4 2024.
- For Q4 2024, Return on Invested Capital fell 913.0% year-over-year to 15.38%; the TTM value through Dec 2024 reached 15.38%, down 913.0%, while the annual FY2024 figure was 3882.59%, 388812.0% up from the prior year.
- Return on Invested Capital reached 15.38% in Q4 2024 per FBIO's latest filing, up from 7.79% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 102.59% in Q1 2024 and bottomed at 111.18% in Q2 2023.
- Average Return on Invested Capital over 4 years is 2.92%, with a median of 0.57% recorded in 2021.
- Peak YoY movement for Return on Invested Capital: crashed -10994bps in 2023, then skyrocketed 12178bps in 2024.
- A 4-year view of Return on Invested Capital shows it stood at 0.85% in 2021, then crashed by -219bps to 2.69% in 2022, then surged by 1010bps to 24.51% in 2023, then tumbled by -37bps to 15.38% in 2024.
- Per Business Quant database, its latest 3 readings for Return on Invested Capital were 15.38% in Q4 2024, 7.79% in Q3 2024, and 10.6% in Q2 2024.